Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Change in Cash (2018 - 2025)

Historic Change in Cash for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $12.2 million.

  • Neurogene's Change in Cash rose 12746.01% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 7957.87%. This contributed to the annual value of -$11.8 million for FY2024, which is 11768.15% down from last year.
  • As of Q3 2025, Neurogene's Change in Cash stood at $12.2 million, which was up 12746.01% from -$12.0 million recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Change in Cash peaked at $103.2 million during Q4 2023, and registered a low of -$65.8 million during Q1 2025.
  • Moreover, its 3-year median value for Change in Cash was -$12.0 million (2025), whereas its average is -$970636.4.
  • The largest annual percentage gain for Neurogene's Change in Cash in the last 5 years was 12746.01% (2025), contrasted with its biggest fall of 383736.51% (2025).
  • Neurogene's Change in Cash (Quarter) stood at $103.2 million in 2023, then plummeted by 32.19% to $70.0 million in 2024, then crashed by 82.57% to $12.2 million in 2025.
  • Its Change in Cash was $12.2 million in Q3 2025, compared to -$12.0 million in Q2 2025 and -$65.8 million in Q1 2025.